<DOC>
	<DOCNO>NCT02822001</DOCNO>
	<brief_summary>The Primary objective study determine whether patient receive sugammadex immediately tracheal extubation exhibit decrease incidence postoperative residual paralysis associate decrease incidence postoperative respiratory depression ( precede critical respiratory event , CRE ) . The Secondary objective : ) determine whether patient receive sugammadex normal TOF ratio ( &gt; 0.90 ) indicative full neuromuscular recovery PACU ; b ) improve patient safety document whether postoperative respiratory depression ( decrease MV 80 % 40 % predict MV assess Respiratory Volume Monitor ) due opioid administration vs. postoperative residual neuromuscular block ( compare postoperative VAS score total opioid administer ) .</brief_summary>
	<brief_title>Sugammadex v . Placebo Prevent Residual Neuromuscular Block Post -- ‐Anesthesia Care Unit</brief_title>
	<detailed_description>The Investigators plan enroll 300 patient undergoing surgical procedure require general anesthesia mechanical ventilation recruit consent obtain . The subject randomize preoperatively receive OR follow procedure prior extubation either sugammadex ( Group 1 , n=150 patient ) placebo ( Group 2 , n=150 patient ) . In patient , intraoperative surgical anesthetic management follow usual clinical routine two enrolling institution . Once surgery finish , emergence anesthesia occur per usual clinical routine clinician determines patient ready tracheal extubation . Once decision extubate trachea make , patient receive intravenously either sugammadex 2 mg/kg placebo blind manner . The patient 's trachea extubated , postoperative anesthetic care proceed per usual routine . Patients transfer PACU postoperative care recovery . ( This methodology ensure 300 patient receive least current standard clinical care . Of 300 patient , 50 % ( n=150 patient ) may benefit administration sugammadex , may decrease incidence residual neuromuscular block . ) 1 . The ExSpiron place patient ' chest prior extubation . ExSpiron data collect start prior tracheal extubation , transport OR PACU , PACU . 2 . Patient care staff blind ExSpiron numerical trending data MV , TV RR , respiratory trace display demonstrate ExSpiron functioning . Of note , gain trace variable size breath visualize screen correlated volume breath . This maintain blind patient care staff . 3 . TOF Monitoring objective monitor ( TOF -- Watch StimPod ) use patient decision extubate patient ' trachea make . The monitoring continue PACU full recovery ( TOF=1.0 ) document . Monitoring perform per usual clinical routine via surface ECG electrodes . In PACU , current amplitude decrease 30 -- ‐40 mA , current intensity use routinely patient care center result patient discomfort . 4 . Patient care staff blind TOF data . Only investigator assign PACU data retrieval know result TOF Monitoring . 5 . Patient care follow standard hospital protocol . 6 . Physiologic monitor clinical assessment data record per standard protocol PACU . 7 . All therapy medication include oxygen , CPAP , opioids sedative deliver accordance standard care . 8 . Doses time medication ( opioids , sedative , etc . ) respiratory intervention ( albuterol , respiratory treatment , suction , high flow oxygen , CPAP , BiPAP , etc . ) record throughout entire perioperative period ( pre -- ‐op , OR , PACU ) . 9 . Pain score base standard analog scale ( 1 -- ‐10 ) record . These obtain per standard clinical practice . 10 . Arterial venous blood gas value Chest x -- ‐rays take OR PACU record obtain part standard care . B . Study Procedures 1 . Screening Recruitment : Study personnel review surgery schedule identify appropriate eligible patient . Eligible patient inform study study explain parent , guardian legal representative . They able ask question . If would like participate , write informed consent obtain . 2 . Randomization : Patients randomize one two group : administration sugammadex ( n=150 ) vs. placebo ( n=150 ) prior tracheal extubation OR . 3 . Prior Procedure ( OR preoperative area ) : I . For RVM monitoring , ExSpiron PadSet place patient 's thorax ( see Appendix A placement instruction ) . Deviations standard placement document . Once OR ExSpiron connect ExSpiron synchronize ventilator . ii . For TOF monitoring , skin ECG electrode place along ulnar nerve volar forearm , per routine clinical protocol . Visual tactile intraoperative monitoring neuromuscular block level perform accord clinician ' usual routine . At end surgery , clinician determine recovery neuromuscular block adequate maintenance spontaneous ventilation , TOF determine objectively ( measure currently available monitor , TOF -- ‐Watch StimPod ) , patient 's trachea extubated , per usual clinical routine . In 150 300 patient , dose sugammadex ( 2 mg/kg ) administer , routine TOF measurement make PACU . 4 . Operating Room ( OR ) : 1 . Record medication ( dose , route , time ) 2 . Record surgery start end time 3 . Record position change 4 . Record intubation extubation time 5 . Recovery Room ( PACU ) : 1 . Record PACU arrival check device function . 2 . Record medication ( dose , route , time ) 3 . Record form dose administer oxygen &amp; change administer oxygen respiratory treatment kind 4 . Record PACU discharge time 5 . MV , TV &amp; RR numerical data hidden available patient care decision , continuous respiratory trace display . Patient care provider use trace clinical decision -- ‐making . If trace absent grossly abnormal , record study staff notify ensure proper device function . 6 . TOF data hidden available patient care decision 6 . Final Discharge Parameters : Record patient ' final discharge date time ( LOS ) PACU . 7 . De -- ‐identification : All study data de -- ‐identified identifying information link code accessible study staff . The code destroy follow final data analysis . 8 . Assessment Subject Safety Data Safety Monitoring Plan : All patient follow one study investigator ensure complication associate sugammadex administration ( flush , tachycardia , hypotension , etc ) . There expect complication RVM monitoring . There expect complication associate TOF monitoring , fact , monitor show improve patient safety decrease postoperative CREs complication . 9 . Subject Participation : 1 . Recruitment : Subjects recruit pre -- ‐ procedure hold area study team member prior surgery . 2 . Screening Interview : Subject screen base study personnel examine surgery schedule next day identify appropriate procedure schedule patient 's eligibility . 3 . Informed consent process time obtain consent : Informed consent obtain study staff prior surgery preoperative hold area , patient require surgery general anesthesia plan extubation OR . After thorough review study . Sufficient time give patient , parent , guardian legal representative ask question decide participation . 4 . Location study perform : University Texas , UTHealth Houston Mayo Clinic , Jacksonville , Florida operate hold area , operate recovery room , intensive care unit applicable . 5 . Personnel conduct study include PI research team member . 10 . Subject fee : There fee study . 11 . Procedures protect subject confidentiality : A unique study ID number assign subject mean de -- ‐identify study data . A code keep separately PI . Study file keep locked office lock cabinet password -- ‐protected computer encrypt study file . The location PI office restrict access . The code lock separately study file PI office . 1 . Certificate Confidentiality : N/A 2 . How data cod , record , store protect confidentiality : All data de -- ‐ identify . All data link subject study ID code . 3 . Data analyze institutional biostatisticians UTHealth Houston . 4 . Parties access data , include key identity code : Jaideep Mehta , MD Sorin J. Brull , MD primary study staff access master study log/key . Other investigator clinical engineering staff Respiratory Motion , Inc. access de -- ‐identified data . 5 . Parties access research record : Investigators study , Respiratory Motion , Inc. access de -- ‐identified record . 6 . Collaboration : This study perform collaboration Respiratory Motion , Inc. 7 . Alternatives : The alternative participating study participate . 8 . How new information convey study subject document : Other initial explanation purpose plan study , investigators n't expect new information become available study could affect subject 's willingness participate . No new information clinical relevance subject expect study . Therefore , new information give patient . 9 . Payment research -- ‐related injury : This minimal risk study . There plan provide compensation . If participant injure study , study doctor discus available medical treatment option subject . 12 . Outcome : The primary outcome study evaluation effect sugammadex incidence respiration complication postoperatively .</detailed_description>
	<mesh_term>Respiratory Insufficiency</mesh_term>
	<mesh_term>Pulmonary Valve Insufficiency</mesh_term>
	<mesh_term>Delayed Emergence Anesthesia</mesh_term>
	<mesh_term>Anesthetics</mesh_term>
	<criteria>Patients undergo surgery general anesthesia , Patients weigh ≥ 80 pound intubated prior surgery , Patients able give inform consent . Patients unable give inform consent . Any patient whose condition allow placement electrode PadSet . Patients whose trachea extubated OR PACU . Patients Impaired Renal Function know estimate CrCl &lt; 30 ml/min Patients use oral contraception .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Sugammadex</keyword>
</DOC>